F Laguna

Summary

Publications

  1. ncbi request reprint Treatment of visceral leishmaniasis in HIV-infected patients: a randomized trial comparing meglumine antimoniate with amphotericin B. Spanish HIV-Leishmania Study Group
    F Laguna
    Servicio de Enfermedades Infecciosas, Centro Nacional de Investigacion Clinica, Instituto de Salud Carlos III, Madrid, Spain
    AIDS 13:1063-9. 1999
  2. ncbi request reprint Treatment of leishmaniasis in HIV-positive patients
    F Laguna
    Servicio de Enfermedades Infecciosas, Hospital Carlos III, Sinesio Delgado 12, 28029 Madrid, Spain
    Ann Trop Med Parasitol 97:135-42. 2003
  3. ncbi request reprint Amphotericin B lipid complex versus meglumine antimoniate in the treatment of visceral leishmaniasis in patients infected with HIV: a randomized pilot study
    Fernando Laguna
    Servicio de Enfermedades Infecciosas, Hospital Carlos III, Instituto de Salud Carlos III, C Sinesio Delgado 12, 28029 Madrid, Spain
    J Antimicrob Chemother 52:464-8. 2003
  4. ncbi request reprint HIV--Leishmania infantum co-infection: humoral and cellular immune responses to the parasite after chemotherapy
    J Moreno
    WHO Collaborating Centre for Leishmaniasis, Research Unit in Tropical Medicine and International Health FIS ISCIII, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain
    Trans R Soc Trop Med Hyg 94:328-32. 2000
  5. ncbi request reprint A nested polymerase chain reaction (Ln-PCR) for diagnosing and monitoring Leishmania infantum infection in patients co-infected with human immunodeficiency virus
    I Cruz
    WHO Collaborating Centre for Leishmaniasis, Servicio de Parasitologia, Centro Nacional de Microbiologia, Instituto de Salud Carlos III, Madrid, Spain
    Trans R Soc Trop Med Hyg 96:S185-9. 2002
  6. ncbi request reprint Relapses versus reinfections in patients coinfected with Leishmania infantum and human immunodeficiency virus type 1
    Miguel A Morales
    World Health Organization Collaborating Centre for Leishmaniasis, Servicio de Parasitologia, Centro Nacional de Microbiologia, Madrid, Spain
    J Infect Dis 185:1533-7. 2002
  7. ncbi request reprint Amphotericin B lipid complex versus no treatment in the secondary prophylaxis of visceral leishmaniasis in HIV-infected patients
    Rogelio Lopez-Velez
    Enfermedades Infecciosas, Hospital Ramon y Cajal, Carretera de Colmenar, Km 9 100, 28034 Madrid, Spain
    J Antimicrob Chemother 53:540-3. 2004
  8. ncbi request reprint [Recommendations of the Spanish AIDS Study Group (GESIDA) and the National Aids Plan (PNS) for antiretroviral treatment in adult patients with human immunodeficiency virus infection in 2002]
    Rafael Rubio
    Hospital 12 Octubre, Madrid, Spain
    Enferm Infecc Microbiol Clin 20:244-303. 2002
  9. ncbi request reprint Prevention of opportunistic infections in adult and adolescent patients with HIV infection. GESIDA/National AIDS Plan guidelines, 2004 [correction]
    Juan Berenguer
    Unidad de Enfermedades Infecciosas, Hospital General Gregorio Maranon, Madrid, Spain
    Enferm Infecc Microbiol Clin 22:160-76. 2004
  10. pmc Correlation of the MIC and dose/MIC ratio of fluconazole to the therapeutic response of patients with mucosal candidiasis and candidemia
    Juan L Rodriguez-Tudela
    Servicio de Micologia, Centro Nacional de Microbiologia, Instituto de Salud Carlos III, Ctra Majadahonda Pozuelo km 2, 28220 Majadahonda, Spain
    Antimicrob Agents Chemother 51:3599-604. 2007

Collaborators

Detail Information

Publications10

  1. ncbi request reprint Treatment of visceral leishmaniasis in HIV-infected patients: a randomized trial comparing meglumine antimoniate with amphotericin B. Spanish HIV-Leishmania Study Group
    F Laguna
    Servicio de Enfermedades Infecciosas, Centro Nacional de Investigacion Clinica, Instituto de Salud Carlos III, Madrid, Spain
    AIDS 13:1063-9. 1999
    ..Visceral leishmaniasis is common in patients with HIV infection living in endemic areas, but the most effective and safe treatment remains unknown...
  2. ncbi request reprint Treatment of leishmaniasis in HIV-positive patients
    F Laguna
    Servicio de Enfermedades Infecciosas, Hospital Carlos III, Sinesio Delgado 12, 28029 Madrid, Spain
    Ann Trop Med Parasitol 97:135-42. 2003
    ..The development of new regimens, use of new oral drugs (such as miltefosine) and the development of new antileishmanial drugs could all improve the treatment of HIV-related VL in the future...
  3. ncbi request reprint Amphotericin B lipid complex versus meglumine antimoniate in the treatment of visceral leishmaniasis in patients infected with HIV: a randomized pilot study
    Fernando Laguna
    Servicio de Enfermedades Infecciosas, Hospital Carlos III, Instituto de Salud Carlos III, C Sinesio Delgado 12, 28029 Madrid, Spain
    J Antimicrob Chemother 52:464-8. 2003
    ..0006). The efficacy of ABLC is similar to meglumine antimoniate, but the severity of toxicity in the treatment of HIV-VL is lower with ABLC...
  4. ncbi request reprint HIV--Leishmania infantum co-infection: humoral and cellular immune responses to the parasite after chemotherapy
    J Moreno
    WHO Collaborating Centre for Leishmaniasis, Research Unit in Tropical Medicine and International Health FIS ISCIII, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain
    Trans R Soc Trop Med Hyg 94:328-32. 2000
    ..would explain the high frequency of relapses reported in these patients. The decreased levels of TGF-beta 1 could have an important role in the interaction between the 2 pathogens...
  5. ncbi request reprint A nested polymerase chain reaction (Ln-PCR) for diagnosing and monitoring Leishmania infantum infection in patients co-infected with human immunodeficiency virus
    I Cruz
    WHO Collaborating Centre for Leishmaniasis, Servicio de Parasitologia, Centro Nacional de Microbiologia, Instituto de Salud Carlos III, Madrid, Spain
    Trans R Soc Trop Med Hyg 96:S185-9. 2002
    ..infantum infection...
  6. ncbi request reprint Relapses versus reinfections in patients coinfected with Leishmania infantum and human immunodeficiency virus type 1
    Miguel A Morales
    World Health Organization Collaborating Centre for Leishmaniasis, Servicio de Parasitologia, Centro Nacional de Microbiologia, Madrid, Spain
    J Infect Dis 185:1533-7. 2002
    ..These results suggest the utility of this PCR-RFLP analysis in detecting leishmaniasis reinfection in HIV-positive patients...
  7. ncbi request reprint Amphotericin B lipid complex versus no treatment in the secondary prophylaxis of visceral leishmaniasis in HIV-infected patients
    Rogelio Lopez-Velez
    Enfermedades Infecciosas, Hospital Ramon y Cajal, Carretera de Colmenar, Km 9 100, 28034 Madrid, Spain
    J Antimicrob Chemother 53:540-3. 2004
    ..The aim of this study was to evaluate the efficacy and safety of amphotericin B lipid complex (ABLC) in preventing VL relapses in HIV-infected patients...
  8. ncbi request reprint [Recommendations of the Spanish AIDS Study Group (GESIDA) and the National Aids Plan (PNS) for antiretroviral treatment in adult patients with human immunodeficiency virus infection in 2002]
    Rafael Rubio
    Hospital 12 Octubre, Madrid, Spain
    Enferm Infecc Microbiol Clin 20:244-303. 2002
    ..Whether to recommend, consider, or not to recommend ART has been established for each situation...
  9. ncbi request reprint Prevention of opportunistic infections in adult and adolescent patients with HIV infection. GESIDA/National AIDS Plan guidelines, 2004 [correction]
    Juan Berenguer
    Unidad de Enfermedades Infecciosas, Hospital General Gregorio Maranon, Madrid, Spain
    Enferm Infecc Microbiol Clin 22:160-76. 2004
    ..To provide an update of guidelines from the Spanish AIDS Study Group (GESIDA) and the National AIDS Plan (PNS) committee on the prevention of opportunistic infections in adult and adolescent HIV-infected patients...
  10. pmc Correlation of the MIC and dose/MIC ratio of fluconazole to the therapeutic response of patients with mucosal candidiasis and candidemia
    Juan L Rodriguez-Tudela
    Servicio de Micologia, Centro Nacional de Microbiologia, Instituto de Salud Carlos III, Ctra Majadahonda Pozuelo km 2, 28220 Majadahonda, Spain
    Antimicrob Agents Chemother 51:3599-604. 2007
    ....